FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2026/01/100701 [Registered on: 09/01/2026] Trial Registered Prospectively
Last Modified On: 08/01/2026
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Ayurveda 
Study Design  Randomized, Parallel Group, Active Controlled Trial 
Public Title of Study   Evaluate the efficacy of Triphala Mandoora in the Management of Pandu Roga (Iron Deficiency Anemia) 
Scientific Title of Study   A Randomized Controlled Open Label Clinical Study to evaluate the efficacy of Triphala Mandoora in the Management of Pandu Roga w.s.r to Iron Deficiency Anemia 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Manik Soni 
Designation  Senior Lecturer ,PG Department of Kayachikitsa 
Affiliation  Rajiv Gandhi Govt Post Graduate Ayurvedic College and Hospital, Paprola 
Address  PG Department of Kayachikitsa ,Room number 317,Rajiv Gandhi Govt Post Graduate Ayurvedic College and Hospital, Paprola, Distt. Kangra,

Kangra
HIMACHAL PRADESH
176115
India 
Phone  82191210414  
Fax    
Email  drmsony@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Manik Soni 
Designation  Senior Lecturer ,PG Department of Kayachikitsa 
Affiliation  Rajiv Gandhi Govt Post Graduate Ayurvedic College and Hospital, Paprola 
Address  PG Department of Kayachikitsa ,Room number 317,Rajiv Gandhi Govt Post Graduate Ayurvedic College and Hospital, Paprola, Distt. Kangra,


HIMACHAL PRADESH
176115
India 
Phone  82191210414  
Fax    
Email  drmsony@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Kanchan Dhiman  
Designation  PG Scholar 
Affiliation  Rajiv Gandhi Govt Post Graduate Ayurvedic College and Hospital,Paprola 
Address  PG Department of Kayachikitsa ,Room number 317,Rajiv Gandhi Govt Post Graduate Ayurvedic College and Hospital, Paprola, Distt. Kangra,

Kangra
HIMACHAL PRADESH
176115
India 
Phone  8219360386  
Fax    
Email  kanchandhiman773@gmail.com  
 
Source of Monetary or Material Support  
Charak Pharmacy Rajiv Gandhi Govt Post Graduate Ayurvedic College and Hospital, Paprola, ,176115 ,Kangra, H.P.,INDIA 
 
Primary Sponsor  
Name  Rajiv Gandhi Govt Post Graduate Ayurvedic College and Hospital, Paprola 
Address  Rajiv Gandhi Govt Post Graduate Ayurvedic College and Hospital, Paprola, Distt. Kangra, H.P. 176115, India 
Type of Sponsor  Research institution and hospital 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Manik Soni  Rajiv Gandhi Govt Post Graduate Ayurvedic College and Hospital, Paprola  Room No.317, Rajiv Gandhi Govt Post Graduate Ayurvedic College and Hospital, Paprola, Distt. Kangra, H.P. 176115, India Kangra HIMACHAL PRADESH
Kangra
HIMACHAL PRADESH 
8219121014

drmsony@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethics Committee(Human) Rajiv Gandhi Govt. Post Graduate Ayurvedic College and Hospital, Paprola, Distt. Kangra, H.P. ,176115, India  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:D508||Other iron deficiency anemias. Ayurveda Condition: PANDUROGAH,  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Intervention ArmDrugClassical(1) Medicine Name: Triphala Mandoora, Reference: Ayurveda Sar Sangraha ( Loha Mandoora Prakarana), Route: Oral, Dosage Form: Gutika/Vati/Ghana Vati/ Tablets, Dose: 250(mg), Frequency: bd, Bhaishajya Kal: Adhobhakta, Duration: 30 Days, anupAna/sahapAna: Yes(details: Lukewarm water), Additional Information: -
2Comparator Arm (Non Ayurveda)-Ferrous Sulphate200mg once a day two hour after meal
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  60.00 Year(s)
Gender  Both 
Details  1.Patients having sign and symptoms of Pandu roga
2.Hb
Male less than 8-12gm
Female less than 7-11 gm
3.Patients willing and able to participate for 8 weeks duration .
4.Indivisuals of either gender between the age 18 -60 years
 
 
ExclusionCriteria 
Details  1.Patients not following in inclusion criteria .
2.Patients suffering from chronic respiratory and cardiac disorder ,CKD or other major illness like carcinoma .
3. Patients who has completed participation in any other clinical trial during the past 3 Month  
 
Method of Generating Random Sequence   Other 
Method of Concealment   Other 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
Improvement in sign and symptom of pandu (Iron Deficiency anemia)  30days 
 
Secondary Outcome  
Outcome  TimePoints 
To asses the safety of TRiphala Mandoora in the management of Pandu Roga (Iron Deficiency anemia )  30 days 
 
Target Sample Size   Total Sample Size="30"
Sample Size from India="30" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   16/03/2026 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Yet Recruiting 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   I would like to publish my research work after completion of the trial as soon as possible. Patients
will be selected from OPD/IPD of RGGPG Ayurvedic College and Hospital,Paprola. 2 groups of 30
patients will be registered and assessed to evaluate the efficacy of Triphala Mandoora in the management of Pandu Roga w.s.r to Iron Deficiency Anemia.
 
Close